Based on these findings, IL-10 was evaluated as a therapeutic target, and recombinant IL-10 therapy has been attempted in rheumatoid arthritis, Crohn's disease, and HIV infection; however, the results have been unsatisfactory. Here, IL10 is linked to Crohn disease.